Package 42367-521-25

Brand: belrapzo

Generic: bendamustine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42367-521-25
Digits Only 4236752125
Product NDC 42367-521
Product ID 42367-521_7e2a2a05-9122-41c0-acf0-a1231a57434e
Description

1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25) / 4 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2019-06-03
Brand belrapzo
Generic bendamustine hydrochloride
Sample Package No

Linked Drug Pages (1)

BELRAPZO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "7e2a2a05-9122-41c0-acf0-a1231a57434e", "openfda": {"upc": ["0342367521256"], "unii": ["981Y8SX18M"], "rxcui": ["1726097", "2178266"], "spl_set_id": ["9759a4ae-82ca-40cf-9c02-e1cadb21cbdc"], "manufacturer_name": ["Eagle Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25)  / 4 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "42367-521-25", "marketing_start_date": "20190603"}], "brand_name": "BELRAPZO", "product_id": "42367-521_7e2a2a05-9122-41c0-acf0-a1231a57434e", "dosage_form": "INJECTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "42367-521", "generic_name": "bendamustine hydrochloride", "labeler_name": "Eagle Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BELRAPZO", "active_ingredients": [{"name": "BENDAMUSTINE HYDROCHLORIDE", "strength": "100 mg/4mL"}], "application_number": "NDA205580", "marketing_category": "NDA", "marketing_start_date": "20190603", "listing_expiration_date": "20261231"}